Carregant...
Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases
To enable the establishment of a drug discovery operation for neglected diseases, out of 2.3 million commercially available compounds 222 552 compounds were selected for an in silico library, 57 438 for a diverse general screening library, and 1 697 compounds for a focused kinase set. Compiling thes...
Guardat en:
| Autors principals: | , , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
WILEY-VCH Verlag
2008
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2628535/ https://ncbi.nlm.nih.gov/pubmed/18064617 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cmdc.200700139 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|